Detalhe da pesquisa
1.
Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity.
Front Immunol
; 10: 1097, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31244822